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Abstract The present work investigates the contribution of
various second messenger systems to Ca2+-induced
phosphatidylserine (PS) exposure in red blood cells (RBCs)
from sickle cell disease (SCD) patients. The Ca2+ dependence
of PS exposure was confirmed using the Ca2+ ionophore
bromo-A23187 to clamp intracellular Ca2+ over 4 orders of
magnitude in high or low potassium-containing (HK or LK)
saline. The percentage of RBCs showing PS exposure was
significantly increased in LK over HK saline. This effect was
reduced by the Gardos channel inhibitors, clotrimazole and
charybdotoxin. Nevertheless, although Ca2+ loading in the
presence of an outwardly directed electrochemical gradient
for K+ stimulated PS exposure, substantial exposure still oc-
curred in HK saline. Under the conditions used inhibitors of
other second messenger systems (ABT491, quinacrine,
acetylsalicylic acid, 3,4-dichloroisocoumarin, GW4869 and
zVAD-fmk) did not inhibit the relationship between [Ca2+]
and PS exposure. Inhibitors of phospholipase A2, cyclooxy-
genase, platelet-activating factor, sphingomyelinase and
caspases, therefore, were without effect on Ca2+-induced PS
exposure in RBCs, incubated in either HK or LK saline.
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Introduction
Aminophospholipids including phosphatidylserine (PS) are
normally confined to the inner leaflet of the plasma membrane
[18]. Exposure is a pathophysiological process associated
with apoptosis as PS is recognised by macrophages and other
targets. A similar occurrence happens in red blood cells
(RBCs) although in this case the term eryptosis is sometimes
used, with that of apoptosis more appropriate for nucleated
cells [18, 21]. Thus, in healthy individuals, only a small
percentage of circulating RBCs show externalisation of PS.
This is important because PS is prothrombotic and exposure
causes RBC removal and thrombus formation [2, 11]. In-
creased PS exposure does occur in various disease states
including sickle cell disease (SCD), in which an increased,
but variable, percentage of RBCs show externalised PS, asso-
ciated with both the anaemic and ischaemic complications of
the condition [5, 18, 19, 26]. As such, the mechanism of
exposure has received considerable attention.
In normal RBCs, asymmetrical distribution of PS is
maintained by an active aminophospholipid translocase (or
flippase) which transports aminophospholipids including PS
from outer to inner leaflet using energy from ATP hydrolysis
[10]. In addition, there is low activity of a Ca2+-dependent
scrambling process (or scramblase), of which the transporter
responsible remains unclear. In RBCs from SCD patients, PS
exposure is associated by a rise in the activity ratio of
scramblase to flippase [1] This can be caused by a number of
factors but elevation of intracellular Ca2+ ([Ca2+]i) has been
proposed as a significant precipitant. High [Ca2+]i will both
inhibit the flippase and activate the scramblase. Recently mem-
bers of the TMEM16 protein family have been identified. They
may function as Ca2+-dependent phospholipid scramblases as
well as Ca2+-dependent Cl- channels [35, 36], and as such may
be important in PS exposure.
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RBCs from SCD patients contain the abnormal
haemoglobin HbS, in which the normal amino acid at the
sixth position of the β chain is replaced with valine [3]. This
substitution allows neighbouring HbS molecules to aggregate
on deoxygenation, forming long polymers which distort RBC
shape (forming the eponymous sickles and other bizarre mor-
phologies) and have other deleterious sequelae. A further
important difference with normal RBCs is a high membrane
permeability to cations [14, 27, 37]. One pathway that is
activated on HbS polymerisation and sickling, and which is
not seen in normal RBCs, is a deoxygenation-induced cation
conductance sometimes termed Psickle [13, 27, 28]. Psickle
activity has several consequences, one of which is entry of
Ca2+. Psickle is therefore associated with deoxygenation-
induced elevation of [Ca2+] [32]. It may therefore encourage
PS exposure. Indeed, we have shown previously that
deoxygenation-induced PS exposure requires extracellular
Ca2+ at physiological concentrations, that Ca2+ entry and
elevation of [Ca2+]i is required, and that inhibitors of the Psickle
pathway also reduce deoxygenation-induced PS exposure [4,
39]. PS exposure in response to elevation of Ca2+ shows a
biphasic response with high and low affinity components,
requiring [Ca2+]i of about 1 and 100 μM, respectively [39].
PS exposure in normal RBCs has also been extensively
investigated in the context of eryptosis [21]. Several other
second messenger pathways besides high [Ca2+]i have been
implicated including cyclooxygenase activity and prostaglan-
din E2 (PGE2) [23], phospholipase A2 (PLA2), platelet-
activating factor (PAF) [23], sphingomyelinase activation
and ceramide production [24, 25], caspases [29], and shrink-
age [20, 22, 25, 31, 33]. These other pathways may interact
with entry of Ca2+ via Psickle. For example, it has been pro-
posed in normal RBCs that PGE2 may open non-specific
cation channels to mediate Ca2+ entry [15–17]. In addition,
there is evidence that Ca2+-induced PS exposure also involves
PKC, likely PKCα [38]. It is therefore important to establish
the extent to which Ca2+-induced PS scrambling is an indirect
phenomenon involving any of these other pathways. In this
study, we investigated this possibility using inhibitors of other
second messenger pathways. Results suggest that neither cy-
clooxygenase, PLA2, PAF, sphingomyelinease, nor caspases
are involved. Activation of the Ca2+-activated K+ channel (or
Gardos channel [9]), with subsequent hyperpolarization or
RBC shrinkage, however, do increase PS exposure.
Materials and methods
Solutions and chemicals
The main experimental saline comprised (in mM): NaCl 140,
KCl 4, MgCl2 0.15, N -2-hydroxyethylpiperzine-N ′-2-
ethanesulphonic acid (HEPES) 10 and inosine 10 with a pH
of 7.4 at 37 °C (low potassium-containing saline, LK saline).
For washing RBCs, a high potassium-containing saline (HK
saline) was usually used, comprising (in mM) NaCl 54, KCl
90, MgCl2 0.15, HEPES 10 and inosine 10 with a pH of 7.4 at
room temperature. For Ca2+ titration curves, EGTA (2 mM)
and appropriate concentrations of extracellular Ca2+
([Ca2+]os) was used to clamp free [Ca
2+]o at 0, 1, 10, 100
and 1,000 μM, with total [Ca2+]os of 0, 1.91, 2.00, 2.10 and
3.00 mM, respectively. RBCs were permeabilised to Ca2+
with the ionophore bromo-A23187 (2.5–6 μM) — control
experiments were carried out to determine [A23187] for max-
imal effects for alteration of [Ca2+]i, PS exposure and also K
+
flux. In control experiments, in the absence of bromo-
A23187, PS exposure over 60 min incubation changed by
<2% (n =3) with no systematic correlation between the extent
of PS exposure and the extracellular calcium concentration.
The ice-cold wash solution for K+ flux measurements com-
prised (in mM): MgCl2 107, 3-(N -morpholino)-
propanesulphonic acid (MOPS) 10, pH 7.4 at 0 °C.
Lactadherin (LA)-binding buffer consisted of LK or HK
HBS with the appropriate [Ca2+]o, 1 mM vanadate and 16
nM LA-FITC. Osmolality of all solutions was 290±
5 mOsm kg−1. Lactadherin-FITC was obtained from
Haematologic Technologies Inc. (Vermont, USA) supplied
via Cambridge Bioscience (Cambridge, UK), anti-
glycophorin A-PE from Becton Dickinson Biosciences (Cal-
ifornia, USA), HEPES and bromo-A23187 from Calbiochem
(Merck, Darmstadt, Germany), the pan caspase inhibitor
zVAD-fmk from Enzo Life Sciences Ltd (Essex, UK) and
86Rb+ from PerkinElmer (MA, USA). All other chemicals
came from Sigma-Aldrich (Poole, Dorset, UK). Stock solu-
tions of ABT491 and quinacrine were made in water; those of
clotrimazole, charybdotoxin, diclofenac, acetylsalicylic acid,
3,4-dichloroisocoumarin, GW4869 and zVAD-fmk in DMSO
(final concentration, 0.5 %). Where it was used as a solvent,
control RBCs were treated with the same [DMSO]. Control
experiments were carried out to investigate the effect of in-
hibitors on intracellular Ca2+. For these, RBCs were loaded
with 5 μM fluo-4-AM for 45 min at 37 °C in the dark (1.5 %
Hct) in HK saline, washed once into HK saline containing
1 μMCa2+, pretreated with second messenger inhibitors prior
to addition of ionophore. Mean fluorescence was then mea-
sured by FACS (see below) and did not vary by>6 % com-
pared to controls in the absence of second messenger inhibi-
tors, indicative of the lack of effect of inhibitors on [Ca2+]i,
with the exception of RBCs incubated with GW4869 in which
mean fluorescence increased by 37 %; however, in this case
RBCs showed some evidence of clumping.
RBCs preparation
Blood samples were collected from HbSS SCD patients, with
consent and ethical permission (11/LO/0065), in the
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anticoagulant EDTA. RBCs were washed three times into HK
HBS for 3 min at 600×g and subsequently twice into LK or
HK HBS with 2 mM EGTA to remove contaminant Ca2+.
RBC suspensions, final haematocrit (Hct) of 0.5 % (except in
Fig. 7, where Hct was initially 5 %), were incubated at 37 °C
for 30 or 60 min in the absence or presence of various second
messenger inhibitors, followed by treatment with bromo-
A23187 (nominally 2.5–6 μM with separate batches titrated
to establish the optimal concentration, final [DMSO] <0.5 %)
at the indicated free [Ca2+]o for 30 min at 37 °C. Vanadate
(1 mM) was present in the last step to inhibit both the flippase
and the plasma membrane calcium pump (PMCA).
Labelling of PS exposure
For PS labelling, 5-μl aliquots (105 RBCs) of each sample
were placed in 250 μl of LA-FITC binding buffer and incu-
bated in the dark at room temperature for 10 min. RBCs were
then pelleted by centrifugation for 10 s at 16,100×g , washed
once in LK or HK HBS to remove unbound LA-FITC and
kept on ice until flow cytometry analysis. Unlike annexin-V,
LA-FITC binds to PS in a Ca2+-independent manner and
control experiments showed that binding was irreversible.
Inhibitors were tested for self-fluorescence at their highest
concentration with unlabelled RBCs.
FACS acquisition and analysis
Externalised PS was measured with LA-FITC using an exci-
tation wavelength of 488 nm in the FL1 channel with an
emission wavelength of 519 nm on a fluorescence-activated
flow cytometer (FACSCalibur, Becton Dickinson, BD) and
analysed with the BD CellQuest Pro software using a protocol
published previously [4]. Measurements were taken using a
logarithmic gain. Forward scatter (FSC, size) and side scatter
(SSC, granularity) gates for RBCs were identified in control
experiments using anti-glycophorin A-PE labelled RBCs. The
positive fluorescent gate was set using RBCs unlabelled with
LA-FITC. For each measurement 10,000 events were gated.
PS positive cells were defined as all events falling within the
preset FSC, SSC and positive fluorescent gates.
K+ flux measurements
Potassium fluxes were measured using 86Rb+ as a tracer for
K+ [6, 34]. RBCs (Hct about 20 %) were first equilibrated in
Eschweiler tonometers (Kiel, Germany) in air at 37 °C,
pH 7.4, in HK saline with added CaCl2 (10 μM) in which
glucose (5 mM) was substituted for inosine and MOPS for
HEPES. Aliquots were then diluted 10-fold into test tubes
containing the same saline with added A23187 (nominally
4 μM). Bumetanide (10 μM) and ouabain (100 μM) were
present to inhibit K+ transport through the Na+–K+–2Cl−
cotransport and Na+/K+ pump. Influx was started by adding
86Rb+ (final activity about 0.05 MBq ml−1) and was
performed in the absence and presence of clotrimazole
(5 μM) over 10 min, to give the activity of the Ca2+-activated
K+ (or Gardos) channel after which RBCs were washed four
times in ice-cold isotonic MgCl2 wash solution, the final cell
pellet lysed with Triton X-100 (0.1 %), protein precipitated
with 5 % trichloroacetic acid and activity was measured as
Čerenkov radiation by liquid scintillation (Packard Tri-carb




Fig. 1 Ca2+-induced exposure of phosphatidylserine (PS) in red blood
cells (RBCs) from patients with sickle cell disease (SCD). a Time course:
RBCs were treated with the ionophore bromo-A23187 (2.5–6 μM) for up
to 60 min in high potassium-containing (HK) saline with 100 μM extra-
cellular [Ca2+] ([Ca2+]o). Symbols represent duplicate measurements from
a single sample. b Ca2+ dependence: RBCs (0.5 % haematocrit, Hct; final
[DMSO] <1 %) were treated with ionophore (2.5–6 μM) for 30 min, in
HK or low potassium-containing (LK) saline, with [Ca2+]o varied be-
tween 0 μM and 1 mM. Symbols represent means±SEM, n =12. *p<
0.05 and **p<0.002 between PS exposure in RBCs incubated in HK or
LK saline
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Statistics
With the exception of those shown in Figs. 1a and 7, all data
are presented as means±SEM for blood samples of n different
SCD patients. Statistical significance was tested with Stu-
dent's t-test, and a p value <0.05 was considered significant.
Results
Ca2+ dependence of PS exposure of RBCs from patients
with SCD
The Ca2+ dependence of PS scrambling was confirmed using
the ionophore bromo-A23187 to clamp intracellular [Ca2+]i.
Due to the Donnan ratio, this method clamps [Ca2+]i at about
double the value of [Ca2+]o [7, 30]. PS scrambling occurred
within minutes with a plateau achieved by 20 min (Fig. 1a). In
all subsequent experiments, therefore, RBCswere treated with
ionophore for 30 min before labelling for PS. Elevation of
[Ca2+]i, as well as causing PS scrambling, will also lead to
activation of the Ca2+-activated K+ channel (or Gardos chan-
nel), and possibly a Ca2+-dependent Cl- channel [35]. In low
potassium-containing (LK) salines, Gardos channel activation
will result in loss of K+ and shrinkage and hyperpolarisation of
the RBC membrane [12]. High potassium-containing salines
(HK saline) were used to prevent these secondary effects.
Typically, a biphasic response was apparent in both HK and
LK salines with the major component of PS scrambling (ac-
counting for about two-thirds of the total) occurring with high
Ca2+ affinity (about 1 μM) and a minor component with low
Ca2+ affinity (about 100 μM, Fig. 1b), as previously reported
[39]. PS exposure was significantly increased in LKHBS. The
Ca2+ affinities, however, appeared unaltered (Fig. 1b). These
Ca2+ titration curves of PS exposure were subsequently used
to investigate the effect of inhibitors of other second messen-
gers, with RBCs left as untreated controls or treated with
second messenger inhibitors for 30 min prior to and also
during alteration of [Ca2+]i with ionophore.
The effect of inhibitors of second messengers in HK saline
The effect of diclofenac (10–500 μM) and acetylsalicylic acid
(50–200 μM) as inhibitors of cyclooxygenase, ABT491 (1–
50 μM) as an antagonist of PAF receptors, quinacrine (25 and
100 μM) as a non-specific PLA2 inhibitor, and two
sphingomyelinase inhibitors, 3,4-dichloroisocoumarin (20 and
200 μM)— a serine proteinase inhibitor— and GW4869 (100
Table 1 Effect of second messenger inhibitors on phosphatidylserine (PS) exposure in red blood cells (RBCs) from sickle cell disease (SCD) patients
[Ca2+]i (μM) in HK saline
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RBCs were treated with the ionophore bromo-A23187 (2.5–6 μM) for 30 min in HK saline in the absence of [Ca2+ ]o and with [Ca
2+ ]o varied between
1 μM and 1 mM. Inhibitors were absent (controls) or added at the concentrations indicated for 30 min prior to, and during, ionophore treatment (0.5 %
Hct, final [DMSO] <1 %). Values represent means±SEM of percentage of RBCs with exposed PS for n individuals. * p<0.05 compared to controls
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nM–10 μM), both active against neutral sphingomyelinase,
were tested on PS scrambling in HK saline. Results are
summarised in Table 1 for the highest inhibitor concentration
used while Fig. 2 shows the effect of ABT491 and of
acetylsalicylic acid over the full range of concentrations used.
None of these reagents decreased the extent of PS exposure in
the Ca2+ titration curves. Diclofenac and GW4896, however,
showed a significant increase in PS exposure at some, but not
all, concentrations (Table 1). For GW4896, this did not require
the presence of Ca2+. In the presence of GW4896 at 10μM there
was some indication of RBC clumping which may have
artefactually increased PS exposure. Such increases were not
present for the alternative cyclooxygenase and sphingomyelinase
inhibitors, acetylsalicylic acid and 3,4-dichloroisocoumarin.
The effect of Gardos channel activity on PS exposure of RBCs
from SCD patients
In the next series of experiments, the effect of Ca2+-induced
K+ efflux via the Gardos channel was investigated. When
RBCs were incubated with the Gardos channel inhibitor clo-
trimazole (5–20 μM, results shown for 20 μM only), PS
a
b
Fig. 3 Involvement of the Ca2+-activated K+ channel (Gardos channel)
in Ca2+-induced PS exposure in RBCs from SCD patients. RBCs were
treated with ionophore for 30 min (as in Fig. 1b). a RBCs were incubated
in either HK or LK HEPES-buffered saline (HBS) in the absence and
presence of 20 μM clotrimazole (CLT). Symbols represent means±SEM,
n =5; black circles LK HBS, black squares LK HBS with CLT (20 μM),
grey triangles HKHBS and grey diamonds HKHBSwith CLT (20 μM).
*p <0.03 between PS exposure in RBC incubated in LK saline in the
presence and absence of CLT, #p <0.05 between LK and HK saline.
b RBCs were incubated in HK or LK saline, in the absence and




Fig. 2 Effect of platelet-activating factor (PAF) and cyclooxygenase
inhibitors on Ca2+-induced PS exposure in RBCs from SCD patients.
RBCs were incubated in HK saline in the presence or absence of inhibitor
for 30 min prior to treatment with ionophore for 30 min (as in Fig. 1b). a
Effect of treatment with the PAF inhibitor ABT491 (1–50 μM). b Effect
of treatment with the cyclooxygenase inhibitor acetylsalicylic acid (50–
200 μM). Symbols represent means±SEM, n =3, except for 5 μM
ABT491, where n =2. There was no significant difference between values
in the presence or absence (controls) of the inhibitors
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exposure in LK saline was reduced (Fig. 3a). Clotrimazole,
however, had no effect on PS exposure in RBCs incubated in
HK saline (Fig. 3a). Charybdotoxin (600 nM), a spider venom
which inhibits the Gardos channel with higher affinity than
clotrimazole, was also tested. Similar to clotrimazole, PS
exposure in LK saline was reduced to levels observed in HK
saline (Fig. 3b). The inhibitory effect of these drugs on Ca2+-
activatedK+ fluxes across the RBCmembranewas confirmed.
With A23187-treated RBCs and [Ca2+]o of 10 μM Ca
2+, K+
influx increased to 386±79 mmol (l cells h)−1 being reduced
to 18±2 (means±SEM, n =9) in the presence of 5 μM clotri-
mazole, an inhibition of 95 %. These findings are consistent
with activation of the Gardos channel with an outwardly
directed K+ gradient responsible for elevation of PS exposure
in LK saline in RBCs permeabilised to Ca2+, as has been
observed in RBCs from normal individuals [22, 31].
The effect of inhibitors of second messengers in LK saline
Although Gardos channel activity likely accounts for the
higher PS exposure in LK saline (compared to HK saline),
other second messenger pathways may also be involved. The
various inhibitors were therefore tested on the augmented PS
exposure observed in LK saline. PS exposure was measured in
LK saline in ionophore-treated RBCs at 1, 10 and 100 μM
a
b
Fig. 4 Effect of cyclooxygenase inhibitors on Ca2+-induced PS exposure
in RBCs from SCD patients. RBCs were incubated in HK saline, LK
saline or LK saline plus inhibitor for 30 min before treatment with
ionophore for 30 min (as in Fig. 1b). a Effect of diclofenac (500 μM).
b Effect of acetylsalicylic acid (200 μM). Histograms represent means±
SEM, n=3. *p <0.05
a
b
Fig. 5 Effect of platelet-activating factor (PAF) and phospholipase A2
(PLA2) inhibitors on Ca2+-induced PS exposure in RBCs from SCD
patients. RBCs were incubated in HK saline, LK saline or LK saline plus
inhibitor for 30 min before treatment with ionophore for 30 min (as in
Fig. 1b). a Effect of the PAF inhibitor ABT491 (50 μM). Histograms
represent means±SEM, n =7. #p<0.05, *p <0.005. b Effect of the
PLA2 inhibitor quinacrine (100 μM). Histograms represent means±
SEM, n =3. *p <0.03
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[Ca2+]o at the highest concentration of inhibitors used in HK
saline (Figs. 4, 5 and 6). In all, there was a significant increase
in PS exposure when comparing RBCs incubated in LK with
those in HK saline. Again, however, there was no significant
difference in PS exposure in the absence or presence of
diclofenac (500 μM), acetylsalicylic acid (200 μM), quina-
crine (100 μM) or 3,4-dichloroisocoumarin (200 μM). While
there was an increase in PS exposure (p <0.05) with ABT491
(50 μM) at a free [Ca2+]i of 10 μM and GW4869 (10 μM) at a
free [Ca2+]i of 100 μM PS exposure at the other [Ca
2+]is was
unchanged. However, none of the drugs used caused an inhi-
bition of PS exposure. Finally, the effect of the pan caspase
inhibitor zVAD-fmk (60 μM) was investigated (Fig. 7) in LK
saline. Again, PS exposure was unaltered.
Discussion
The present work investigates the contribution of various
other secondmessenger systems to Ca2+-induced PS exposure
in RBCs from SCD patients. Inhibitors of cyclooxygenase,
PAF, PLA2, sphingomyelinase and caspases were without
effect. By contrast, the percentage of RBCs showing PS
exposure was significantly increased under circumstances
which allowed K+ exit through the Ca2+-activated K+ channel
(or Gardos channel). This effect was inhibited by the Gardos
channel inhibitors, clotrimazole and charybdotoxin.
The assay chosen for the current investigation was a Ca2+
titration curve in which RBCs were treated with bromo-
A23187 and different levels of extracellular Ca2+ to alter the
free [Ca2+]i between 0.1 μM and 1 mM. This allows the
visualisation of both high and low Ca2+ affinities of PS scram-
bling [4, 39], a process that begins within 5 min and is
complete within 20 min. The assay used enables any effects
of second messenger inhibitors to be observed as either a
change in Ca2+ affinity of the scrambling process or as a
change of the percentage of RBCs showing PS exposure.
Under the conditions chosen, however, Ca2+-induced scram-
bling did not appear to involve cyclooxygenase, PAF, PLA2,
sphingomyelinase and caspases in either HK saline or in LK
saline. Increases in PS exposure with diclofenac and GW4869
did occur but were variable, inconsistent between HK and LK
salines, and not observed with alternative inhibitors of the same
a
b
Fig. 6 Effect of sphingomyelinase (SMase) inhibitors on Ca2+-induced
PS exposure in RBCs from SCD patients. RBCs were incubated in HK
saline, LK saline or LK saline plus inhibitors for 30 min before treatment
with ionophore for 30 min (as in Fig. 1b). a Effect of the Mg2+-dependent
neutral SMase inhibitor GW4869 (10 μM). Histograms represent means±
SEM, n =6. b Effect of the SMase inhibitor 3,4-dicloroisocoumarin
(200 μM). Histograms represent means±SEM, n=6. *p<0.03, #p<0.05
Fig. 7 Effect of the caspase inhibitor zVAD-fmk on Ca2+-induced PS
exposure in RBCs from SCD patients. RBCs (5%Hct) were incubated in
LK saline for 60 min in the absence or presence of zVAD-fmk
(60 μM) prior to treatment with ionophore (30 min, at 0.5 % Hct,
as in Fig. 1b). Results are from a single experiment representative
of four different SCD patients
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pathways (acetylsalicylic acid and 3,4-dichloroisocoumarin),
perhaps indicative of a non-specific effect. The time taken for
RBCs to traverse the microvasculature in vivo will usually be
seconds to minutes, so these findings suggest that relatively
brief elevations of intracellular [Ca2+] would probably need to
act directly if they are to stimulate the scrambling process.
PS exposure involved in the process of RBC eryptosis has
received considerable attention and has emerged as a complex
eventwithmany potential stimuli. Cyclooxygenase and PGE2 [8,
23], PAF and PLA2 [23], sphingomyelinase and ceramide [24,
25] and caspases [29] have all been implicated in PS exposure
using inhibitor studies and reagents similar to those described
here. These previous reports differ in the use of normal human
(HbAA) RBCs, with one exception [26]. They also usually
involve relatively prolonged incubation of RBCs with reagents
tested on PS exposure over several hours to days (e.g., [25, 26]).
The shorter term effects described in the current work may be
more relevant to the initial trapping of PS-exposing RBCs via
interaction with phagocytes or activated endothelial cells. The
Ca2+ signal alone would appear to contribute to the initial PS
exposure under these conditions, with other important pathways
investigated in the present work becoming involvedmore slowly
and playing an additional role in stimulating PS exposure.
Gardos channels have previously been shown to increase PS
exposure in response to Ca2+ loading in normal (HbAA) human
RBCs [22, 31]. In addition, treatment with the K+ ionophore
valinomycin to increase K+ permeability directly also increases
PS exposure [33]. We observed similar effects in RBCs from
SCD patients. Thus in contrast to cyclooxygenase, PAF, PLA2,
sphingomyelinase and caspase activity, activation of the Gardos
channel in the presence of an outwardly directed electrochemical
gradient for K+ was associated with a rise in the percentage of
RBCs showing PS exposure. The rise of PS was inhibited by
removing the gradient for K+ loss (HK saline) or by inhibition of
the channel directly with either clotrimazole or charybdotoxin,
as shown previously in RBCs from normal individuals [22, 31].
When activated, K+ channels will cause hyperpolarization of the
RBCmembrane as well as solute loss and shrinkage [12]. It has
been suggested that the increased negative potential difference
acts to increase Ca2+ entry and hence elicit PS exposure [22].
The lack of effect on Ca2+ affinity in the titration curves (e.g.,
Fig. 1b), however, suggests that this is not the case. It is also
important to realise, nevertheless, that the considerable PS
exposure in HK saline implies that K+ efflux and its sequelae
are not prerequisites of Ca2+-induced PS exposure. Similarly,
although high K+ may directly inhibit scrambling [40], this
effect was not sufficient to prevent considerable PS exposure
in RBCs from SCD patients.
In conclusion, Ca2+-induced PS exposure in RBCs from SCD
patients does not appear to involve a number of second messen-
gers in the time scale of the present experiments. K+ efflux,
probably via shrinkage, however, does increase externalization
of PS.
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